Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
Custom Molded Shoes: If the Shoe Doesn’t Fit…
TOP STORIES — Diabetes News and Research
The Preservation of Beta Cell Function in Patients with Type 1 Diabetes
Diabetes Patients At Risk for Myocardial Infarctions Even Without CAD
SGLT-2 Inhibitors’ Association with Fournier Gangrene
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
Editor's Note
When my wife was first diagnosed with diabetes, I wanted to start insulin on the first day. My thinking was to save pancreatic function for as long as possible. This turned out to be good in the long run as she was later diagnosed with LADA and is now on an insulin pump. It seems that anything we can do to try to slow the destruction of the Beta Cells would be a positive thing, and this week our intern Emma Kammerer, L|E|C|O|M Bradenton School of Pharmacy, has a feature on the use of a humanized anti-CD3 monoclonal antibody to improve and sustain beta cell function.
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
A patient of mine who had diabetes and peripheral neuropathy came home from the hospital after a below-the-knee amputation of her right leg.
She lived alone and was housebound. Having lost one leg, I knew she was at increased risk for losing her other leg.
While in rehab, she had a professionally custom molded shoe made for her left foot which she started to wear.
TOP STORIES — Diabetes News and Research
What are the long-term effects of teplizumab on C-peptide response?
DE-MRI shows asymptomatic patients are undergoing small, silent heart attacks.
While rare, Fournier gangrene infections can worsen rapidly and have serious consequences.
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.